Based on ACR tips, allopurinol is strongly advisable as a first-line urate-lowering medication. Genetic screening is usually recommended (for any variant called HLA B*5801) ahead of starting up allopurinol since the carriers of the gene are at an increased hazard of the serious allergic reaction.